EUR RADIOL 2019 10.1007/s00330-019-06198-5
Value of blood oxygenation level-dependent MRI for predicting clinical outcomes in uterine cervical cancer treated with concurrent chemoradiotherapy
Lee1, J; Kim, CK; Gu, KW; Park, W

EUR RADIOL 2019 10.1007/s00330-019-06204-w
Prognostic value of ADC quantification for clinical outcome in uterine cervical cancer treated with concurrent chemoradiotherapy
Gu1, KW; Kim, CK; Choi, CH; Yoon, YC; Park, W

BREAST 2019 10.1016/j.breast.2019.06.005
Is higher dose radiation necessary for positive resection margin after breast-conserving surgery for breast cancer?
Cho1, WK; Choi, DH; Park, W; Kim, H; Cha, H

SCI REP-UK 2019 10.1038/s41598-019-51959-3
Anti-Tumor Effects of Wee1 Kinase Inhibitor with Radiotherapy in Human Cervical Cancer
Lee1, YY; Cho, YJ; Shin, SW; Choi, C; Ryu, JY; Jeon, HK; Choi, JJ; Hwang, JR; Choi, CH; Kim, TJ; Kim, BG; Bae, DS; Park, W; Lee, JW

CANCER RES TREAT 2019 10.4143/crt.2018.423
Korean First Prospective Phase II Study, Feasibility of Prone Position in Postoperative Whole Breast Radiotherapy: A Dosimetric Comparison
Chung1, Y; Yu, JI; Park, W; Choi, DH

CLIN BREAST CANCER 2019 10.1016/j.clbc.2019.04.003
The Characteristics of Local Recurrence After Breast-Conserving Surgery Alone for Malignant and Borderline Phyllodes Tumors of the Breast (KROG 16-08)
Choi1, N; Kim, K; Shin, KH; Kim, Y; Moon, HG; Park, W; Choi, DH; Kim, SS; Do Ahn, S; Kim, TH; Chun, M; Kim, YB; Kim, S; Choi, BO; Kim, JH

CANCER RES TREAT 2019 10.4143/crt.2018.575
Impact of Regions Nodal Irradiation or Breast Cancer Patients with Supraclavicular and/or Internal Mammary Lymph Node Involvement: A Multicenter, Retrospective Study (KROG 16-14)
Kim1, K; Jeong, Y; Shin, KH; Kim, JH; Ahn, SD; Kim, SS; Suh, CO; Kim, YB; Choi, DH; Park, W; Cha, J; Chun, M; Lee, DS; Lee, SY; Kim, JH; Park, HJ; Jung, W

TUMORI 2019 10.1177/0300891618792476
Baseline neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in rectal cancer patients following neoadjuvant chemoradiotherapy
Kim1, TG; Park, W; Kim, H; Choi, DH; Park, HC; Kim, SH; Cho, YB; Yun, SH; Kim, HC; Lee, WY; Lee, J; Kang, KM

J BREAST CANC 2019 10.4048/jbc.2019.22.e42
Gastric Complications after Adjuvant Radiotherapy for Breast Cancer
Cho1, WK; Choi, DH; Park, W; Kim, H; Kim, S; Shin, MH; Cha, H

INT J GYNECOL CANCER 2019 10.1136/ijgc-2019-000615
Para-aortic lymph node recurrence after curative radiotherapy for cervical cancer
Cho1, WK; Kim, YI; Park, W; Yang, K; Kim, H; Cha, H

CANCER RES TREAT 2019 10.4143/crt.2018.424
Comparison of Breast Conserving Surgery Followed by Radiation Therapy with Mastectomy Alone for Pathologic N1 Breast Cancer Patients in the Era of Anthracycline Plus Taxane-Based Chemotherapy: A Multicenter Retrospective Study (KROG 1418)
Yoo1, GS; Park, W; Yu, JI; Choi, DH; Kim, YJ; Shin, KH; Wee, CW; Kim, K; Park, KR; Kim, YB; Ahn, SJ; Lee, JH; Kim, JH; Chun, M; Lee, HS; Kim, JS; Cha, J

BREAST J 2019 10.1111/tbj.13304
Heart-sparing radiotherapy with three-dimensional printing technology after mastectomy for patients with left breast cancer
Yang1, K; Park, W; Ju, SG; Chung, Y; Choi, DH; Cha, H; Park, JY; Shin, JS; Na, CH

J BREAST CANC 2019 10.4048/jbc.2019.22.e25
The Benefit of Post-Mastectomy Radiotherapy in ypN0 Patients after Neoadjuvant Chemotherapy According to Molecular Subtypes
Cho1, WK; Park, W; Choi, DH; Kim, YB; Kim, JH; Kim, SS; Kim, K; Kim, JH; Ahn, SJ; Lee, SY; Lee, J; Kim, SW; Kwon, J; Ahn, KJ

BREAST 2019 10.1016/j.breast.2019.02.010
Is tumor bed boost necessary in patients who achieved ypCR following neoadjuvant chemotherapy and breast conserving therapy? (KROG 12-05 and 16-16)
Cho1, WK; Park, W; Choi, DH; Kim, YB; Su, CO; Shin, KH; Chie, EK; Kim, JH; Ahn, SD; Kim, SS; Kim, K; Kim, JH; Ahn, SJ; Lee, SY; Lee, J; Kim, SW; Kwon, J; Ahn, KJ; Shin, HS; Lee, HS; Lee, NK

CANCERS 2019 10.3390/cancers11050680
Clinical Significance of Lymph-Node Ratio in Determining Supraclavicular Lymph-Node Radiation Therapy in pN1 Breast Cancer Patients Who Received Breast-Conserving Treatment (KROG 14-18): A Multicenter Study
Kim1, J; Park, W; Kim, JH; Choi, DH; Kim, YJ; Lee, ES; Shin, KH; Kim, JH; Kim, K; Kim, YB; Ahn, SJ; Lee, JH; Chun, M; Lee, HS; Kim, JS; Cha, J

J BREAST CANC 2019 10.4048/jbc.2019.22.e1
Central Nervous System Failure in Korean Breast Cancer Patients with HER2-Enriched Subtype: Korean Radiation Oncology Group 16-15 Multicenter Retrospective Study
Kim1, K; Shin, KH; Kim, JH; Choi, DH; Park, W; Kim, YB; Kim, HJ; Kim, JH; Park, H; Lee, SY; Kim, J; Oh, DH; Kim, IA

BREAST 2019 10.1016/j.breast.2018.11.004
Adjuvant radiation therapy in small ductal carcinoma in situ
Cho1, WK; Choi, DH; Kim, H; Noh, JM; Park, W; Cha, H

CLIN BREAST CANCER 2019 10.1016/j.clbc.2018.08.009
Role of Elective Nodal Irradiation in Patients With ypN0 After Neoadjuvant Chemotherapy Followed by Breast-Conserving Surgery (KROG 16-16)
Cho1, WK; Park, W; Choi, DH; Kim, YB; kim, JH; Kim, SS; Kim, K; Kim, JH; Ahn, SJ; Lee, SY; Lee, J; Kim, SW; Kwon, J; Ahn, KJ

HERED CANCER CLIN PR 2019 10.1186/s13053-018-0103-3
The association between non-breast and ovary cancers and BRCA mutation in first- and second-degree relatives of high-risk breast cancer patients: a large-scale study of Koreans
Kim1, H; Choi, DH; Park, W; Im, YH; Ahn, JS; Park, YH; Nam, SJ; Kim, SW; Lee, JE; Yu, JH; Lee, SK; Jung, BY

PLoS One 2019 10.1371/journal.pone.0209998
A multi-institutional study of bladder-preserving therapy for stage II-IV bladder cancer: A Korean Radiation Oncology Group Study (KROG 14-16)
Byun1, SJ; Park, W; Cho, KH; Cho, J; Chang, AR; Kang, KM; Kim, JH; Kim, JH